| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 授权生产许可费(元) | - | - | - | 33,079,245.28 | 29,499,622.64 |
| 原料(元) | - | - | - | - | 61,011,240.98 |
| 制剂(元) | 159,996,236.92 | 304,947,019.56 | 176,622,582.68 | 254,068,223.03 | 95,369,396.05 |
| 原料(含药用级、食品级)(元) | 54,766,926.43 | 147,798,372.00 | 67,535,535.09 | 135,664,056.63 | - |
| 其他(元) | 4,534,769.06 | 11,057,463.49 | 4,254,856.19 | 7,087,585.48 | 2,194,529.51 |
| 营业成本(元) | |||||
| 授权生产许可费(元) | - | - | - | 1,276,411.20 | 963,245.50 |
| 原料(元) | - | - | - | - | 37,589,226.41 |
| 制剂(元) | 72,875,096.60 | 129,755,086.94 | 72,907,296.92 | 120,319,441.15 | 51,521,347.67 |
| 原料(含药用级、食品级)(元) | 37,109,403.61 | 95,520,022.21 | 42,411,394.56 | 82,486,705.75 | - |
| 其他(元) | 4,254,895.82 | 5,632,788.97 | 2,219,620.35 | 3,990,982.08 | 858,899.55 |
| 毛利(元) | |||||
| 授权生产许可费(元) | - | - | - | 31,802,834.08 | 28,536,377.14 |
| 原料(元) | - | - | - | - | 23,422,014.57 |
| 制剂(元) | 87,121,140.32 | 175,191,932.62 | 103,715,285.76 | 133,748,781.88 | 43,848,048.38 |
| 原料(含药用级、食品级)(元) | 17,657,522.82 | 52,278,349.79 | 25,124,140.53 | 53,177,350.88 | - |
| 其他(元) | 279,873.24 | 5,424,674.52 | 2,035,235.84 | 3,096,603.40 | 1,335,629.96 |
| 毛利率(%) | |||||
| 授权生产许可费(%) | - | - | - | 96.14 | 96.73 |
| 原料(%) | - | - | - | - | 38.39 |
| 制剂(%) | 54.45 | 57.45 | 58.72 | 52.64 | 45.98 |
| 原料(含药用级、食品级)(%) | 32.24 | 35.37 | 37.20 | 39.20 | - |
| 其他(%) | 6.17 | 49.06 | 47.83 | 43.69 | 60.86 |
| 收入构成(%) | |||||
| 授权生产许可费(%) | - | - | - | 7.69 | 15.69 |
| 原料(%) | - | - | - | - | 32.44 |
| 制剂(%) | 72.96 | 65.75 | 71.10 | 59.10 | 50.71 |
| 原料(含药用级、食品级)(%) | 24.97 | 31.87 | 27.19 | 31.56 | - |
| 其他(%) | 2.07 | 2.38 | 1.71 | 1.65 | 1.17 |
| 毛利构成(%) | |||||
| 授权生产许可费(%) | - | - | - | 14.34 | 29.38 |
| 原料(%) | - | - | - | - | 24.11 |
| 制剂(%) | 82.93 | 75.22 | 79.25 | 60.29 | 45.14 |
| 原料(含药用级、食品级)(%) | 16.81 | 22.45 | 19.20 | 23.97 | - |
| 其他(%) | 0.27 | 2.33 | 1.56 | 1.40 | 1.37 |